FDA OKs Boston Scientific's New Taxus Stent
Boston Scientific Corp. has received federal clearance to bring its Taxus Liberte drug-eluting stent to market after waiting more than two years due to regulatory problems at the company's facilities....To view the full article, register now.
Already a subscriber? Click here to view full article